Human Health

We collaborate closely with our clients

to build a healthier future.

End-to-end support for your drug discovery and development programs

For over 20 years, QIMA Life Sciences has been partnering with pharmaceutical and biotech companies to accelerate the development of therapeutic candidates, from early research to clinical validation.

We offer a comprehensive range of non-GLP services covering in vitro and ex vivo studies, preclinical models, clinical research on healthy and patient volunteers, and advanced chemical analytics.

A flexible, science-driven approach

We understand that each project is unique. Our teams work closely with you to define customized and pragmatic study designs, with a strong focus on:

  • Feasibility assessment
  • Scientific rationale
  • Fast and agile execution
  • Transparent project management

Your dedicated study manager ensures continuous communication between your teams and our experts in biology, pharmacology, chemistry and clinical science.

Molecular and cellular pharmacology: areas of research

Pharmaceutical products and active ingredients

  • Natural extracts (plant, marine, bacterial)
  • Synthetic molecules, peptides, proteins, glycoproteins, lipids
  • Biotherapies and biosimilars (antibodies, growth factors)
  • Formulations (creams, gels, lotions)
  • Medical devices

Main areas of Research Support

  • 2nd or 3rd intention screening
  • Target Identification
  • Target Characterization
  • Target Validation
  • Mechanism of Action
  • Comparative Studies
  • Predictor of Response & Disease Course
  • Biomarker Identification
  • Efficacy Testing
  • Biodistribution
  • Establishment of Assays
  • Activity profiling
  • Proof-of-concept, study of mechanism of action
  • Confirmatory assay
  • Biosimilarity

Latest Insights in Pharma & Biotech

SCIENTIFIC NEWS & AGENDA